Back to top
more

Medtronic (MDT)

(Delayed Data from NYSE)

$82.29 USD

82.29
8,732,273

+0.91 (1.12%)

Updated May 24, 2024 04:00 PM ET

After-Market: $82.49 +0.20 (0.24%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.08%
2Buy17.91%
3Hold9.44%
4Sell5.10%
5Strong Sell2.55%
S&P50011.04%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

B Value C Growth D Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 37% (93 out of 250)

Industry: Medical - Products

Better trading starts here.

Zacks News

Medtronic's (MDT) OmniaSecure Lead Favored in the LEADR Trial

Medtronic's (MDT) OmniaSecure defibrillation lead demonstrates reliable performance in the LEADR Pivotal trial.

Medtronic (MDT) Q4 Earnings Beat Estimates, Margins Down

Growth across Cranial & Spinal Technologies, Diabetes, Cardiac Pacing and Surgical businesses contributes to Medtronic's (MDT) Q4 revenues.

Compared to Estimates, Medtronic (MDT) Q4 Earnings: A Look at Key Metrics

While the top- and bottom-line numbers for Medtronic (MDT) give a sense of how the business performed in the quarter ended April 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Medtronic (MDT) Q4 Earnings and Revenues Surpass Estimates

Medtronic (MDT) delivered earnings and revenue surprises of 0.69% and 1.80%, respectively, for the quarter ended April 2024. Do the numbers hold clues to what lies ahead for the stock?

Medtronic's (MDT) MiniMed 780G AID System Wins New Accolade

Medtronic's (MDT) MiniMed 780G system gets recognized among Fast Company's 2024 World Changing Ideas.

Medtronic (MDT) Reports Favorable SPHERE Per-AF Trial Outcome

Medtronic's (MDT) Affera Mapping and Ablation System with Sphere-9 Catheter achieves endpoints for safety and efficacy for the treatment of AFib.

Unlocking Q4 Potential of Medtronic (MDT): Exploring Wall Street Estimates for Key Metrics

Get a deeper insight into the potential performance of Medtronic (MDT) for the quarter ended April 2024 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for some of its key metrics.

Investors Heavily Search Medtronic PLC (MDT): Here is What You Need to Know

Medtronic (MDT) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

Medtronic (MDT) Advances While Market Declines: Some Information for Investors

In the closing of the recent trading day, Medtronic (MDT) stood at $83.52, denoting a +0.82% change from the preceding trading day.

Exagen Inc. (XGN) Reports Q1 Loss, Tops Revenue Estimates

Exagen (XGN) delivered earnings and revenue surprises of 52.50% and 9.21%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?

Moumi Mondal headshot

Here's How Medtronic (MDT) Is Placed Ahead of Q4 Earnings

Medtronic's (MDT) rapid cadence of new product approvals is a strong foundation for future growth. However, the company also navigates some macroeconomic challenges.

Apyx Medical (APYX) Reports Q1 Loss, Tops Revenue Estimates

Apyx (APYX) delivered earnings and revenue surprises of -22.22% and 6.27%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?

National Vision (EYE) Q1 Earnings Top Estimates

National Vision (EYE) delivered earnings and revenue surprises of 7.14% and 2.68%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?

Bio-Rad Laboratories (BIO) Q1 Earnings Surpass Estimates

Bio-Rad (BIO) delivered earnings and revenue surprises of 12.25% and 0.23%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?

Medtronic (MDT) Rises Yet Lags Behind Market: Some Facts Worth Knowing

The latest trading day saw Medtronic (MDT) settling at $81.76, representing a +0.09% change from its previous close.

Medtronic PLC (MDT) is Attracting Investor Attention: Here is What You Should Know

Recently, Zacks.com users have been paying close attention to Medtronic (MDT). This makes it worthwhile to examine what the stock has in store.

Medtronic (MDT) Rises Higher Than Market: Key Facts

Medtronic (MDT) closed at $80.86 in the latest trading session, marking a +1.4% move from the prior day.

Medtronic PLC (MDT) Is a Trending Stock: Facts to Know Before Betting on It

Zacks.com users have recently been watching Medtronic (MDT) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.

Medtronic (MDT) Laps the Stock Market: Here's Why

Medtronic (MDT) reachead $80.57 at the closing of the latest trading day, reflecting a +1.37% change compared to its last close.

Here's Why You Should Retain Medtronic (MDT) Stock for Now

Investors continue to be optimistic about Medtronic (MDT) due to the strength of its Neurosurgery and Cardiovascular portfolios.

The Zacks Analyst Blog Highlights Mastercard, Netflix, Coca-Cola, Berkshire Hathaway and Medtronic

Mastercard, Netflix, Coca-Cola, Berkshire Hathaway and Medtronic are included in this Analyst Blog.

Medtronic (MDT) Stock Sinks As Market Gains: What You Should Know

Medtronic (MDT) concluded the recent trading session at $79.35, signifying a -1.1% move from its prior day's close.

Sheraz Mian headshot

Q1 Earnings Scorecard and Analyst Reports for Mastercard, Netflix & Coca-Cola

Today's Research Daily features a real-time update on the Q1 earnings season and new research reports Mastercard (MA), Netflix (NFLX) and Coke (KO) and others.

Medtronic PLC (MDT) is Attracting Investor Attention: Here is What You Should Know

Zacks.com users have recently been watching Medtronic (MDT) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.

Medtronic's (MDT) Sphere-360 PFA Study Outcome Favorable

Medtronic's (MDT) Sphere-360 catheter is designed to simplify the atrial fibrillation process while increasing efficiency and giving long-lasting lesions.